Andrew S Boyer's Net Worth

$2.33 Million

Estimate Recalculated May 20, 2024 03:13PM EST

Who is Andrew S Boyer?

Andrew S Boyer has an estimated net worth of $2.33 Million. This is based on reported shares across multiple companies, which include Amneal Pharmaceuticals, Inc., and WATSON PHARMACEUTICALS INC.

SEC CIK

Andrew S Boyer's CIK is 0001239546

Past Insider Trading and Trends

2019 was Andrew S Boyer's most active year for acquiring shares with 7 total transactions. Andrew S Boyer's most active month to acquire stocks was the month of February. 2023 was Andrew S Boyer's most active year for disposing of shares, totalling 11 transactions. Andrew S Boyer's most active month to dispose stocks was the month of February. 2003 saw Andrew S Boyer paying a total of $291,900.00 for 7,500 shares, this is the most they've acquired in one year. In 2005 Andrew S Boyer cashed out on 62,400 shares for a total of $1,110,720.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Amneal Pharmaceuticals, Inc. (AMRX) Snapshot price: $5.365

Executive Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+22.91%
59.53K
$5.47
-$332,472.07
319.38K
Mar 1 - Mar 4
Form 4
+6.17%
15.11K
$5.71
-$94,534.76
259.85K
Feb 27
Form 4
-10.69%
-29.30K
$4.13
-$120,920.56
244.74K
Aug 11
Form 4
+4.39%
11.52K
$3.10
-$35,870.10
274.04K
Jun 30
Form 4
+8.05%
19.57K
$1.92
-$37,795.20
262.52K
Mar 3
Form 4
+9.34%
20.75K
$2.09
-$48,001.03
242.95K
Mar 1
Form 4
+6.78%
14.11K
$2.16
-$37,923.12
222.2K
Feb 27
Form 4
+5.86%
11.51K
$3.18
-$36,830.76
208.1K
Jun 30
Form 4
+4.41%
8.3K
$3.40
-$28,400.20
196.58K
May 7
Form 4
+13.09%
21.79K
$4.45
-$97,566.25
188.28K
Mar 1 - Mar 3
Form 4
+10.07%
15.23K
$4.59
-$75,432.06
166.49K
Feb 27
Form 4
+8.24%
11.51K
$5.12
-$59,304.96
151.26K
Jun 30
Form 4
+6.32%
8.3K
$5.20
-$43,435.60
139.75K
May 7
Form 4
0
0
Mar 1
Form 4
+19.57%
21.52K
$5.33
-$119,936.95
131.45K
Feb 27 - Mar 1
Form 4
0
0
Aug 1
Form 4
+8.17%
8.3K
$3.55
-$29,653.15
109.93K
May 7
Form 4
+5.90%
5.66K
$3.85
-$25,729.55
101.63K
Mar 1
Form 4
0
0
Feb 27
Form 4
0
0
Nov 13
Form 4
+227.51%
66.67K
$2.89
$192,664.74
95.97K
Aug 7
Form 4
+184.43%
19K
$9.46
$179,740.00
29.3K
May 13
Form 4
+415.10%
8.3K
$13.44
-$112,264.32
10.3K
May 7
Form 4
0
0
Mar 1
Form 4
2K
2K
May 4 - May 7
Form 3
0
0
No matching records found

WATSON PHARMACEUTICALS INC No price found

SVP,Sales&Mktg,US Generics

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.08%
-1.65K
$41.37
-$68,425.98
38.91K
Mar 14
Form 4
+32.78%
10.02K
40.57K
Feb 24
Form 4
-0.88%
-270.00
$34.63
-$9,350.10
30.55K
Aug 12
Form 4
-2.66%
-843.00
$27.34
-$23,047.62
30.82K
Mar 11
Form 4
+46.02%
9.98K
31.66K
Mar 5
Form 4
-4.18%
-946.00
$30.31
-$28,673.26
21.68K
Sep 1
Form 4
+82.05%
10.2K
22.63K
Mar 12
Form 4
-2.13%
-270.00
$31.12
-$8,402.40
12.43K
Aug 10
Form 4
+69.32%
5.2K
12.7K
Jun 26
Form 4
+349.97%
5.83K
7.5K
Sep 1
Form 4
0
$30.95
-$290,622.00
1.67K
Aug 22
Form 4
1.67K
1.67K
Aug 12
Form 4
-100.00%
-1.93K
$27.94
-$53,776.50
0
Aug 12
Form 4
0
0
Aug 9
Form 4
0
0
Aug 4
No matching records found